UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrating Multiscale Modeling with Drug Effects for Cancer Treatment

Cancer Informatics, 2015-01, Vol.2015 (Suppl. 5), p.21-31

2015

Volltextzugriff (PDF)

Time-Based Switching Control of Genetic Regulatory Networks: Toward Sequential Drug Intake for Cancer Therapy

Cancer informatics, 2017, Vol.2017 (16), p.1176935117706888-1176935117706888

2017

Volltextzugriff (PDF)

Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer

Cellular oncology (Dordrecht), 2024-10, Vol.47 (5), p.1831-1843

2024

Volltextzugriff (PDF)

A Systems Biology Approach in Therapeutic Response Study for Different Dosing Regimens-a Modeling Study of Drug Effects on Tumor Growth using Hybrid Systems

Cancer informatics, 2012-01, Vol.2012 (11), p.41-60

2012

Volltextzugriff (PDF)

Circulating S100A4 as a prognostic biomarker for patients with nonparoxysmal atrial fibrillation after catheter ablation

Annals of translational medicine, 2021-09, Vol.9 (18), p.1400-1400

2021

Volltextzugriff (PDF)

The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (13), p.3360-3371

2012

Volltextzugriff (PDF)

HucMSC‐Exosome Mediated‐Wnt4 Signaling Is Required for Cutaneous Wound Healing

Stem cells (Dayton, Ohio), 2015-07, Vol.33 (7), p.2158-2168

2015

Volltextzugriff (PDF)

Exosomes in cancer: small particle, big player

Journal of hematology and oncology, 2015-07, Vol.8 (1), p.83-83, Article 83

2015

Volltextzugriff (PDF)

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression

Molecular cancer, 2018-10, Vol.17 (1), p.155-155

2018

Volltextzugriff (PDF)

Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition

Carcinogenesis (New York), 2015-04, Vol.36 (4), p.459-468

2015

Volltextzugriff (PDF)

Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes

Journal of hematology and oncology, 2021-01, Vol.14 (1), p.21-21, Article 21

2021

Volltextzugriff (PDF)

Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression

Tumor biology, 2016-09, Vol.37 (9), p.12169-12180

2016

Volltextzugriff (PDF)

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.48-15, Article 48

2019

Volltextzugriff (PDF)

CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy

Journal of experimental & clinical cancer research, 2024-05, Vol.43 (1), p.134-134, Article 134

2024

Volltextzugriff (PDF)

The effects of Roy's adaptation model and the forgetting curve in the clinical instruction of operating room nursing interns

American journal of translational research, 2021-01, Vol.13 (7), p.8214-8220

2021

Volltextzugriff (PDF)

CD161 + CD127 + CD8 + T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus

Oncoimmunology, 2024-12, Vol.13 (1), p.2371575

2024

Volltextzugriff (PDF)

Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer

Journal for immunotherapy of cancer, 2021-04, Vol.9 (4), p.e002343

2021

Volltextzugriff (PDF)

Immune cells within tertiary lymphoid structures are associated with progression‐free survival in patients with locoregional recurrent breast cancer

Cancer medicine (Malden, MA), 2024-01, Vol.13 (1), p.e6864-n/a

2024

Volltextzugriff (PDF)

Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy

Cancer discovery, 2021-12, Vol.11 (12), p.3142-3157

2021

Volltextzugriff (PDF)

MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor

Frontiers in oncology, 2021-06, Vol.11, p.715193-715193

2021

Volltextzugriff (PDF)

Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.271-271, Article 271

2019

Volltextzugriff (PDF)

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Frontiers in oncology, 2023-09, Vol.13, p.1169333-1169333

2023

Volltextzugriff (PDF)

Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes

Biomarker research, 2024-10, Vol.12 (1), p.115-5, Article 115

2024

Volltextzugriff (PDF)

The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties

Oncogene, 2019-06, Vol.38 (25), p.4932-4947

2019

Volltextzugriff (PDF)

AMT-562, a novel HER3-targeting antibody drug conjugate, demonstrates a potential to broaden therapeutic opportunities for HER3-expressing tumors

Molecular cancer therapeutics, 2023-09, Vol.22 (9), p.1013-1027

2023

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieFood Chemistry

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(72)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Integrating Multiscale Modeling with Drug Effects for Cancer Treatment

Time-Based Switching Control of Genetic Regulatory Networks: Toward Sequential Drug Intake for Cancer Therapy

Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer

A Systems Biology Approach in Therapeutic Response Study for Different Dosing Regimens-a Modeling Study of Drug Effects on Tumor Growth using Hybrid Systems

Circulating S100A4 as a prognostic biomarker for patients with nonparoxysmal atrial fibrillation after catheter ablation

The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

HucMSC‐Exosome Mediated‐Wnt4 Signaling Is Required for Cutaneous Wound Healing

Exosomes in cancer: small particle, big player

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression

Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition

Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes

Exosomes derived from gastric cancer cells activate NF-κB pathway in macrophages to promote cancer progression

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy

The effects of Roy's adaptation model and the forgetting curve in the clinical instruction of operating room nursing interns

CD161 + CD127 + CD8 + T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus

Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer

Immune cells within tertiary lymphoid structures are associated with progression‐free survival in patients with locoregional recurrent breast cancer

Tumor Microenvironment-Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy

MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor

Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment

Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes

The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties

AMT-562, a novel HER3-targeting antibody drug conjugate, demonstrates a potential to broaden therapeutic opportunities for HER3-expressing tumors

Aktive Filter

Suchergebnisse filtern